Investment Opportunities
Invest In Growth
Why Invest in Bicaro Holding?
Bicaro Holding offers a unique opportunity to invest in Asia’s first fully licensed and vertically integrated medical-cannabis ecosystem — combining cultivation, research, wellness, and biotech innovation under one trusted platform.
Regulated Market Access
Thailand leads Asia in legal medical-cannabis cultivation, supported by a transparent policy framework and active government endorsement.
Official Thai Licenses
Fully approved indoor and outdoor cultivation facilities operating under GACP standards and Thai FDA oversight.
EU-GMP Roadmap
Progressing toward EU-GMP certification for future export-grade and pharmaceutical production.
Strong Government Relations
Collaborating with Thai health authorities and research institutions to ensure long-term regulatory compliance and policy alignment.
Multi-Revenue Ecosystem
Diversified income from medical cannabis supply, CBD wellness products, and the Bicaroland wellness tourism project.
IPO 2031 Vision
Clear roadmap toward public listing, designed to scale investor value and expand global market reach.
Investment Highlights
Discover the key advantages that make Bicaro Holding a trusted, high-performance opportunity in Asia’s regulated cannabis market.
Strong ROI Potential
Projected returns of up to 200% over a 3–5 year investment period through licensed and scalable operations.
Quarterly Return
Regular quarterly profit sharing, providing stable and transparent returns for investors.
Sustainable Income
Our operations and market positioning ensure stable and sustainable returns for our investors.
Medical-Grade & Export Ready
GACP-certified production and a roadmap to EU-GMP ensure readiness for international medical and pharmaceutical exports.
Investment Packages
Professional cannabis cultivation investment backed by industry expertise, certified operations, and a track record of consistent, proven returns.
Medical Cannabis Cultivation Units
Unit-based investment packages Participate in Bicaro Holding’s regulated cultivation ecosystem through our unit-based investment model — a professionally managed, asset-backed opportunity designed for sustainable returns.
100
Minimum Plants
200%
Projected ROI
3-4
Years Lock-In
Q4
Distributions
Key Features
- Licensed & GACP-compliant cultivation
- Professionally managed operations
- Transparent quarterly returns
- Asset-backed investment model
- EU-GMP roadmap & export readiness
Our Roadmap
Bicaro Holding’s roadmap drives expansion through compliant operations and strategic partnerships, ensuring scalable growth and consistent investor returns.
2024
Initiate large-scale cultivation with organic practices and yield optimization under GACP-aligned operations.
2025-2026
Advance biotechnology research, genetics development, and wellness product formulation for medical and consumer markets.
2027
Complete EU-GMP compliance roadmap, expand international distribution, and prepare for public listing to scale global reach.
